PAB
PATRYS LIMITED
$0.0300
0.00%
Market cap
$20M
Turnover
$1,475
Last price
$0.0300
Day change
0.00%
Announcements
13
Range, past year
Open 0.002 · Low 0.001 · Now 0.030 · High 0.052
Open PAB in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
PAB momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-29.
Momentum quality
34/100
Wyckoff phase
Accumulation23d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
-9.1%
1 Month
+0.0%
1 Year
+0.0%
RSI
37
Avg daily range
3.9%
PATRYS LIMITED scores 34 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Accumulation, where it has been for 23 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
What stands out
- Volume 1.7× 60-day avg
Points to watch
- 60d drawdown -25.0%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
PAB announcements
Recent price-sensitive releases.
- 2026-09-29 Patrys Completes Cohort 1 Dosing and Follow-Up Progress Report
- 2026-09-28 Appendix 4E Variance Report Preliminary Final Report
- 2026-09-23 First Participants Dosed in RLS-2202 Phase 1A Clinical Trial Progress Report
- 2026-09-17 PAB Establishes Clinical Advisory Committee Progress Report | Company Administration - Other
- 2026-08-31 Appendix 4E - Preliminary Final Report Preliminary Final Report
- 2026-08-28 Ethics Approval Secured for Phase 1A Clinical Trial Progress Report
- 2026-07-27 Investor Presentation - TechKnow Invest Roadshow Company Presentation
More Health Care stocks
Most traded in the same sector.